Viewing Study NCT00555594

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:27 AM
Ignite Modification Date: 2026-02-25 @ 6:56 PM
Study NCT ID: NCT00555594
Status: COMPLETED
Last Update Posted: 2024-08-01
First Post: 2007-11-07
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Prospective Study to Determine the Effect of Subconjunctival Bevacizumab (AVASTIN) in Corneal Neovascularization
Sponsor: Asociación para Evitar la Ceguera en México
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Corneal Neovascularization View
Keywords:

Keywords

Keyword Brief Keyword Text View
None corneal neovascularization View
None Bevacizumab (Avastin) View
None Immunologic rejection View
None vascular endothelial growth factor View